SCHEMBL31716623

SCHEMBL31716623

CC(C)(C)OC(=O)Cc1cnc2ccc(CF)cc2c1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAOB P27338 4/20 0.42
RIPK1 Q13546 1/20 0.40
RIPK3 Q9Y572 1/20 0.40
MTNR1A P48039 2/20 0.38
MTNR1B P49286 2/20 0.38
ALDH1A1 P00352 2/20 0.38
KDM4E B2RXH2 1/20 0.38
HPGD P15428 2/20 0.36
F2 P00734 1/20 0.36
GLA P06280 1/20 0.36
KLKB1 P03952 1/20 0.35
MET P08581 1/20 0.33
KDR P35968 1/20 0.33
PDGFRB P09619 1/20 0.33
PDGFRA P16234 1/20 0.33
PDE10A Q9Y233 1/20 0.32
CCNB2 O95067 1/20 0.32
CCNE2 O96020 1/20 0.32
CDK1 P06493 1/20 0.32
CDK4 P11802 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31735602 0.84 ALDH1A1 (0.56) MAOBALDH1A1KDM4EHPGDF2
SCHEMBL2697370 0.83 RIPK1 (0.40) MAOBRIPK1RIPK3MTNR1AMTNR1B
SCHEMBL6241356 0.83 KDM4E (0.48) MAOBALDH1A1KDM4ERAB9ASMN1; SMN2
SCHEMBL1492677 0.81 ALDH1A1 (0.53) RIPK1RIPK3MTNR1AMTNR1BALDH1A1
SCHEMBL31716593 0.80 MAOB (0.49) MAOBRIPK1RIPK3MTNR1AMTNR1B
SCHEMBL31716696 0.79 GABRP (0.46) MAOBALDH1A1KDM4EHPGDPDE10A
SCHEMBL2698219 0.77 ALDH1A1 (0.43) MAOBRIPK1RIPK3MTNR1AMTNR1B
SCHEMBL117104 0.74 MTNR1A (0.41) MAOBRIPK1RIPK3MTNR1AMTNR1B
SCHEMBL29750566 0.73 MTNR1A (0.36) MAOBRIPK1RIPK3MTNR1AMTNR1B
SCHEMBL27033549 0.73 KDR (0.50) RIPK1KLKB1KDRPDGFRBPDGFRA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025227032-A1 METHODS FOR DEGRADATION OF CYCLIN K AND INHIBITION OF CYCLIN DEPENDENT KINASES REMIX THERAPEUTICS INC. (US) 2025-10-30 WO disclosed